Drug profile · INN
lypressin
DIAPID
lypressin (DIAPID) is a vasopressin receptor agonist. Route of administration: nasal. Current US regulatory status: approved.
Drug details — lypressin
- US status
- approved
- Class
- —
- Route
- NASAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
lypressin (DIAPID) is a vasopressin receptor agonist. Route of administration: nasal. Current US regulatory status: approved.
Key facts
Mechanism of action
Vasopressin receptor agonist
Primary target: Vasopressin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is lypressin?
lypressin (DIAPID) is a vasopressin receptor agonist. Route of administration: nasal. Current US regulatory status: approved.
What is the brand name for lypressin?
DIAPID is a marketed brand name for lypressin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lypressin?
lypressin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.